Seek Labs Awarded $2 Million Federal Grant for a Novel CRISPR-Based Therapeutic to Combat Avian Flu
Seek Labs, a private TechBio company building a programmable disease response platform to detect, protect, and counter disease threats, has been awarded $2 million from the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) to develop a novel, mutation-resistant therapeutic for highly pathogenic avian influenza (HPAI) using the company’s proprietary Programmable Target Ablation Platform (PTAP). The award is part of a broader federal push aimed at combating avian influenza, which has led to poultry production disruption, higher egg and poultry prices, and strained food supply...
To Read Full Story Login Below.
Submit comment or question
Note: All comments are displayed with user's screen name. If screen name is not present, user's full name will be used. Please go to My Account to update your screen name.
Comment Policy: Urner Barry has made the comment feature available to encourage further discussion of our news stories. Defamatory or offensive comments, or comments deemed not relevant to the story will be removed, and if necessary, Urner Barry may restrict the right of individual subscribers to offer comments. In all cases, comments represent opinions of the poster only, and do not represent fact, news, opinions or estimates put forward by Urner Barry.
Email Address is required. Password is required.